Systems Software

Bio-Key

Bio-Key released FY2025 9 Months earnings on November 14 Pre-Market (EST), actual revenue USD 4.854 M, actual EPS USD -0.5071

Bio-Key released FY2025 Q3 earnings on November 14 Pre-Market (EST), actual revenue USD 1.55 M (forecast USD 1.8 M), actual EPS USD -0.1464

BIO-key International Reports Q3 2025 Earnings and Strategic Updates

Bio-Key to Release FY2025 Q3 Earnings on November 14, Pre-Market EST; Forecast Revenue USD 1.8 M

Bio-Key released FY2025 Semi-Annual earnings on August 13 Pre-Market (EST), actual revenue USD 3.304M, actual EPS USD -0.3614

Bio-Key released FY2025 Q2 earnings on August 13 Pre-Market (EST), actual revenue USD 1.697 M (forecast USD 1.7 M), actual EPS USD -0.2005

Bio-Key to Release FY2025 Q2 Earnings on August 13 Pre-Market EST, Forecast Revenue USD 1.7 M

BIO-key International Partners with Spanish ISMS Forum for Cybersecurity

BIO-key International Secures $600,000 Order from Department of Defense

BIO-key CEO Acquires Shares

BIO-key and Runlevel Partner to Deploy IAM System in Mozambican Bank

BIO-key and Cloud Distribution Collaborate to Enhance Biometric Security in the Middle East

Bio-Key released FY2025 Q1 earnings on May 15 After-Market EST, actual revenue USD 1.607 M (forecast USD 1.3 M), actual EPS USD -0.1566

BIO-key Releases Q1 2025 Financials and Strategic Outlook

Bio-Key to Release FY2025 Q1 Earnings on May 16 After-Market EST, Forecast Revenue USD 1.3 M

Bio-Key released FY2024 Q4 earnings on March 27 Pre-Market EST, actual revenue USD 1.462 M (forecast USD 2.29 M), actual EPS USD -0.4565

Bio-Key released FY2024 annual earnings on March 27 Pre-Market EST, actual revenue USD 6.93 M (forecast USD 7.752 M), actual EPS USD -2.0878

BIO-Key International Q4 Financial Report: Revenue of $300,000, Net Loss of $1.6 Million

BIO-Key International Expects a Loss of $0.35 per Share and Revenue of $2.29 Million for 2024

Bio-Key to Release FY2024 Q4 Earnings on March 27, 2025, Pre-Market EST; Forecasted Revenue: 2.29 M USD

Intelligent Bio Solutions

Anghami

UTime

ESH ACQUISITION CORP COM USD0.0001 CL A (S/R 13/06/2028)

Northann

FG MERGER II CORP COM USD0.0001 11/02/2030 (SUBS/RTS)

ESH Acquisition

INFLECTION POINT ACQUISITION CORP V COM USD0.0001 CL A (SUB/RIGHST)

RISING DRAGON ACQUISITION CORP COM USD0.0001 15/11/2028 (SUBS/RT)

Datavault AI

微软

现在服务

飞塔信息

Check Point 软件

UiPath

Monday.com

杜比实验室

康沃系统

科力斯

Radware

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Bio-Key(BKYI.US)